Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Acology Closes Strong ‘17, Readies for Big ‘18

Posted on: 28 Dec 17

CORONA, Calif., Dec. 28, 2017 (GLOBE NEWSWIRE) -- Acology Inc. (OTCMKTS:ACOL) announced today that they have completed talks with EZ Health Solutions and will begin manufacturing new CBD products early next year.  Pre-orders will be offered in products which will cover pain-management, energy and holistic health, to Acology’s more than 4500 global distributors.  In addition, Acology will be offering direct sales to the general public in the very near future. With this agreement Acology is moving to capture a share of what The Hemp Business Journal has called an “estimated $2.1B market by 2020.” Forbes estimates that the CBD industry will increase by 700% within 2 years.

As 2017 closes Acology also finds itself pursuing intellectual properties that will help boost the value of its portfolio and complement its expanding line of products and services. Acology finds itself in an excellent position to take advantage of several burgeoning markets, including medical and recreational cannabis, health care, senior care and veterinary care. In addition, their wholly-owned subsidiary, D&C Distributors LLC, efficiently covers more than 25 countries world-wide. Acology’s product lines now include its signature product, the MedTainer™, hydroponic equipment, 2-way humidifiers, collective and retail store products and, soon, CBD products. Customer satisfaction in every aspect of its operation, including manufacturing, shipping, marketing, social media, art production and product branding has never been higher, achieving a better than 98.5%.

Acology management has worked diligently to bring the company to this position. 2018 is expected to be an exceptional year for investors and consumers and where, hopefully, the hard work pays off.

For investor or sales information please visit Acology Inc. and D&C Distributors online or by phone. The company is located in their production and distribution facility at 1620 Commerce St. Corona, California, 92880.

Acology trades on the OTC under the call letters ACOL. The company’s websites are for the hospice and palliative care industry and for the recreational and medical marijuana industry. Orders for Acology products can be taken online and by phone. Custom orders are especially welcome.  Please send all inquiries to or call (844) ACOLOGY (844-226-5649). Ask for Jack Rein, National Services Director.  Acology can also be accessed through Twitter and Instagram at @Acologyinc

This press release includes statements that are covered by the Private Securities Litigation Reform Act of 1995. Because such statements deal with future events they are subject to risks and uncertainties and actual results for fiscal year 2016 and beyond could differ materially from the company’s current expectations. Forward-looking statements are identified by such words as “anticipates”, “projects”, “expects”, “planned”, “intends”, “believes”, “estimate”, “targets” and other similar expressions that indicate trends and future events. It is understood that investment entails risk on the part of the investor and could result in the loss of some or all his or her investment.


Last updated on: 29/12/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.